Eloralintide
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Eli Lilly · Phase 1 · Recruiting · Enrollment 56
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Eloralintide Cohort 1 | n/r | n/r | n/r | n/r | n/r |
| Eloralintide Cohort 2 | n/r | n/r | n/r | n/r | n/r |
| Eloralintide Cohort 3 | n/r | n/r | n/r | n/r | n/r |
| Eloralintide Cohort 4 | n/r | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.